Loading viewer...
investor_presentation
Format: PDF investor_presentation
Specialty pharmaceutical company combining Aytu and Neos operations with a focus on pediatric therapeutics, consumer health products, and rare disease treatments. The company leverages a national specialty salesforce and differentiated formulations to compete in large therapeutic categories including ADHD, with a late-stage pipeline addressing vascular Ehlers-Danlos Syndrome and difficult-to-treat infections.
presentation
investor_presentation
38 Pages
Koninklijke Philips N.V.
Mid-America Apartment Communities Investor Presentation — March 2021
investor_presentationinvestor_presentation
31 Pages
Mid-America Apartment Communities